Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,471.50
-201.00 (-7.52%)
Nov 6, 2026, 3:30 PM JST
Astellas Pharma Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,379,992 | 2,139,245 | 1,912,323 | 1,603,672 | 1,518,619 | 1,296,163 |
Revenue Growth | 18.59% | 11.87% | 19.25% | 5.60% | 17.16% | 3.73% |
Gross Profit Gross Profit Growth | 1,924,067 | 1,730,819 | 1,563,117 | 1,311,187 | 1,230,266 | 1,043,154 |
Operating Income Operating Income Growth | 501,055 | 439,275 | 263,540 | 124,606 | 231,652 | 218,145 |
Net Income Net Income Growth | 385,577 | 291,535 | 50,747 | 17,045 | 98,714 | 124,086 |
Earnings Per Share EPS Growth | 214.52 | 162.22 | 28.24 | 9.47 | 54.09 | 67.05 |
EPS Growth | 208.71% | 474.43% | 198.21% | -82.49% | -19.33% | 3.31% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
USA USA Growth | 1,065,422 | 945,722 | 871,903 | 668,551 | 658,247 | 544,103 |
Japan Japan Growth | 334,957 | 317,057 | 280,106 | 286,218 | 284,844 | 268,940 |
Others Others Growth | - | 876,466 | 760,314 | 648,903 | 575,528 | 483,120 |
Total Total Growth | 2,377,845 | 2,139,245 | 1,912,323 | 1,603,672 | 1,518,619 | 1,296,163 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 238,228 | 281,605 | 188,372 | 335,687 | 376,840 | 315,986 |
Total Debt Total Debt Growth | 424,921 | 672,353 | 937,086 | 1,007,915 | 204,224 | 213,420 |
Net Cash (Debt) Net Cash Growth | -186,693 | -390,748 | -748,714 | -672,228 | 172,616 | 102,566 |
Net Cash Growth | - | - | - | - | 68.30% | 116.09% |
Net Cash Per Share Net Cash Per Share Growth | -103.87 | -217.43 | -416.61 | -373.53 | 94.58 | 55.42 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 547,645 | 560,188 | 194,512 | 172,475 | 327,767 | 257,444 |
Capital Expenditures CapEx Growth | -56,180 | -57,723 | -37,003 | -38,056 | -36,441 | -30,739 |
Free Cash Flow Free Cash Flow Growth | 491,465 | 502,465 | 157,509 | 134,419 | 291,326 | 226,705 |
Free Cash Flow Growth | 34.26% | 219.01% | 17.18% | -53.86% | 28.50% | -17.70% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 80.84% | 80.91% | 81.74% | 81.76% | 81.01% | 80.48% |
Operating Margin | 21.05% | 20.53% | 13.78% | 7.77% | 15.25% | 16.83% |
Pretax Margin | 20.98% | 17.60% | 1.63% | 1.56% | 8.72% | 12.10% |
Profit Margin | 16.20% | 13.63% | 2.65% | 1.06% | 6.50% | 9.57% |
FCF Margin | 20.65% | 23.49% | 8.24% | 8.38% | 19.18% | 17.49% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 80.000 | 78.000 | 74.000 | 70.000 | 60.000 | 50.000 |
Dividend Per Share Growth | 2.56% | 5.41% | 5.71% | 16.67% | 20.00% | 19.05% |
Dividend Yield | 3.24% | 3.10% | 5.12% | 4.26% | 3.19% | 2.60% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 11.52 | 15.48 | 51.03 | 172.88 | 34.26 | 28.37 |
Forward PE | 12.30 | 14.08 | 18.73 | 21.06 | 15.87 | 16.50 |
P/FCF Ratio | 9.02 | 8.98 | 16.44 | 21.92 | 11.61 | 15.53 |
PS Ratio | 1.86 | 2.11 | 1.35 | 1.84 | 2.23 | 2.72 |